These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2437052)

  • 21. Mediator release from human basophils and mast cells from lung and intestinal mucosa.
    Fox CC; Kagey-Sobotka A; Schleimer RP; Peters SP; MacGlashan DW; Lichtenstein LM
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):130-6. PubMed ID: 2409011
    [No Abstract]   [Full Text] [Related]  

  • 22. Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction.
    Flint KC; Leung KB; Hudspith BN; Brostoff J; Pearce FL; Johnson NM
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):923-6. PubMed ID: 2412632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
    Benyon RC; Robinson C; Church MK
    Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of human intestinal mucosal mast cells.
    Fox CC; Dvorak AM; Peters SP; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1985 Jul; 135(1):483-91. PubMed ID: 2582045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
    Schleimer RP; Schulman ES; MacGlashan DW; Peters SP; Hayes EC; Adams GK; Lichtenstein LM; Adkinson NF
    J Clin Invest; 1983 Jun; 71(6):1830-5. PubMed ID: 6134755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mast cells and lysozyme positive macrophages in bronchoalveolar lavage from patients with sarcoidosis. Valuable prognostic and activity marking parameters of disease?
    Bjermer L; Bäck O; Roos G; Thunell M
    Acta Med Scand; 1986; 220(2):161-6. PubMed ID: 3776690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
    Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of nedocromil sodium and sodium cromoglycate on human lung mast cells obtained by bronchoalveolar lavage and by dispersion of lung fragments.
    Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Pearce FL
    Eur J Respir Dis Suppl; 1986; 147():223-6. PubMed ID: 2429855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacologic control of mediator release from human basophils and mast cells.
    Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
    Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Airway levels of mast cell-derived mediators in exercise-induced asthma.
    Broide DH; Eisman S; Ramsdell JW; Ferguson P; Schwartz LB; Wasserman SI
    Am Rev Respir Dis; 1990 Mar; 141(3):563-8. PubMed ID: 1689974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and sensitivity of human mesenteric mast cells to immunological and nonimmunological histamine releasers.
    Brzezińska-Błaszczyk E; Czuwaj M
    Agents Actions; 1987 Apr; 20(3-4):226-8. PubMed ID: 2440277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.
    Triggiani M; Cirillo R; Lichtenstein LM; Marone G
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):253-5. PubMed ID: 2468619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selectively enhanced sensitivity of bronchoalveolar lavage fluid (BALF) mast cells to IgE dependent stimulation in mild asthmatics.
    Xie H; He S; Chen P
    Asian Pac J Allergy Immunol; 2003 Jun; 21(2):83-8. PubMed ID: 14629125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoalveolar lavage in the asthmatic.
    Godard P; Bousquet J; Lebel B; Michel FB
    Bull Eur Physiopathol Respir; 1987; 23(1):73-83. PubMed ID: 3593998
    [No Abstract]   [Full Text] [Related]  

  • 36. Histamine levels in bronchoalveolar lavage from patients with asthma, sarcoidosis, and idiopathic pulmonary fibrosis.
    Rankin JA; Kaliner M; Reynolds HY
    J Allergy Clin Immunol; 1987 Feb; 79(2):371-7. PubMed ID: 2434547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bronchoalveolar lavage in patients with bronchial asthma].
    Płusa T
    Pneumonol Alergol Pol; 1991; 59(1-2):7-15. PubMed ID: 1843892
    [No Abstract]   [Full Text] [Related]  

  • 38. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology.
    Massey WA; Guo CB; Dvorak AM; Hubbard WC; Bhagavan BS; Cohan VL; Warner JA; Kagey-Sobotka A; Lichtenstein LM
    J Immunol; 1991 Sep; 147(5):1621-7. PubMed ID: 1715365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of bronchoalveolar lavage cellularity in stage III pulmonary sarcoidosis.
    Cantin A; Bégin R; Rola-Pleszczynski M; Boileau R
    Chest; 1983 Mar; 83(3):485-6. PubMed ID: 6825482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
    Schildge J; Klar B; Hardung-Backes M
    Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.